Chronic depression in women

Journal of Clinical Psychiatry

Volumn 63, Issue 7, 2002, Pages 602-609

  Kornstein, Susan G ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; MOCLOBEMIDE; NEFAZODONE; PHENELZINE; RITANSERIN; SERTRALINE; TIANEPTINE; TRICYCLIC ANTIDEPRESSANT AGENT;

COMORBIDITY; DEPRESSION; DISABILITY; DISEASE COURSE; DRUG EFFICACY; DYSTHYMIA; FUNCTIONAL DISEASE; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HUMAN; MENSTRUAL CYCLE; MENTAL HEALTH; ONSET AGE; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PSYCHOSOCIAL DISORDER; PSYCHOTHERAPY; REVIEW; SEX DIFFERENCE;

EID: 0036070915     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v63n0713     Document Type: Review

References (92)

1. The natural history and heterogeneity of depressive disorders: Implications for rational antidepressant therapy
2. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
3. Long-term outcome of episodes of major depression
4. Time to recovery, chronicity, and levels of psychopathology in major depression: A 5-year prospective follow-up of 431 subjects
5. Recovery after five years of unremitting major depressive disorder
6. Recurrence after recovery in unipolar MDD: An observational follow-up study of clinical predictors and somatic treatment as a mediating factor
7. Implication of failing to achieve successful long-term maintenance treatment of recurrent unipolar depression
8. DSM-IV mood disorder field trial investigation results
9. Double depression: Two-year follow-up
10. Treatment of chronic depression
11. Sex differences in rates of depression: Cross-national perspectives
12. The epidemiology of dysthymia in five communities: Rates, risks, comorbidity and treatment
13. The persistent risk of chronicity in recurrent episodes of nonbipolar major depressive disorder: A prospective follow-up
14. Sex and depression in the National Comorbidity Survey, 1: Lifetime prevalence, chronicity, and recurrence
15. First-episode major depression: Few sex differences in course
16. Do depressed men and women respond similarly to cognitive behavior therapy?
17. The natural history of depressive symptoms
18. The Zurich Study XII, Sex differences in depression: Evidence from longitudinal epidemiological data
19. 12-Month outcome of patients with major depression and comorbid psychiatric or medical illness (compound depression)
20. Factors associated with 1-year outcome of major depression in the community
21. A prospective follow-up of patients with bipolar and primary unipolar affective disorder
22. The National Depressive and Manic Depressive Association consensus statement on the undertreatment of depression
23. The treatment of chronic depression, pt 2: A double-blind, randomized trial of sertraline and imipramine
24. The undertreatment of dysthymia
25. Sex differences in psychiatric help-seeking: Evidence from four large-scale surveys
26. Gender differences in chronic major and double depression
27. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses
28. The course of depression in adult outpatients: Results from the Medical Outcomes Study
29. Recovery and major depression: Factors associated with twelve-month outcome
30. The treatment of chronic depression, pt 3: Psychosocial functioning before and after treatment with sertraline or imipramine
31. Thirty-month naturalistic follow-up study of early-onset dysthymic disorder: Course, diagnostic stability, and prediction of outcome
32. The economic burden of depression in 1990
33. Disability and depression among high utilizers of health care
34. Lost human capital from early-onset chronic depression
35. Patterns of psychopathology and dysfunction in high-risk children of parents with panic disorder and major depression
36. Screening for depression in mothers bringing their offspring for evaluation or treatment of depression
37. Self-esteem and depression: Ten year follow-up of mothers and offspring
38. Maternal depression effects on infants and early interventions
39. Prevalence and comorbidity of dysthymic disorder among psychiatric outpatients
40. Gender differences in chronic depression
41. Association between major depressive disorder and physical illness
42. Pharmacotherapy of dysthymia
43. Pharmacotherapy of dysthymia: A review
44. Strategies and tactics in the treatment of chronic depression
45. Chronicity of depressive episode in relation to antidepressant-placebo response
46. Sertraline versus imipramine to prevent relapse in chronic depression
47. Atypical antipsychotic drugs in dysthymia: Placebo controlled studies of amisulpride versus imipramine, versus amineptine
48. Imipramine treatment for chronic depression
49. Moclobemide compared with imipramine treatment of chronic depression (dysthymia DSM-III-R): A double-blind placebo-controlled trial
50. Chronic depression: Response to placebo, imipramine, and phenelzine
51. A placebo-controlled randomized trial comparing sertraline and imipramine for the treatment of dysthymia
52. Double-blind study of imipramine versus phenelzine in melancholias and dysthymic disorders
53. Moclobemide and imipramine in chronic depression (dysthymia): An international double-blind placebo-controlled trial
54. Efficacy of tianeptine in anxious-depressed patients: Results of a controlled multicenter trial versus amitriptyline
55. Efficacy of desipramine in depressed outpatients: Response according to research criteria diagnosis and severity of illness
56. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia
57. Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: A double-blind comparative study
58. Controlled efficacy study of fluoxetine in dysthymia
59. Treatment of dysthymia with sertraline: A double-blind, placebo-controlled trial of dysthymic patients without major depression
60. A comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination for the treatment of chronic depression
61. Controlled comparison of RO-11-1163 (moclobemide) in the treatment of depression
62. Psychopharmacologic treatment response of patients with a DSM-III diagnosis of dysthymic disorder
63. 5-HT2 receptor antagonism in dysthymic disorder: A double-blind placebo-controlled study with ritanserin
64. Thymostenic effects of ritanserin (R55667), a centrally acting serotonin S-2 receptor blocker
65. Maintenance therapy for chronic depression: A controlled clinical trial of desipramine
66. Maintenance phase efficacy of sertraline for chronic depression: A double-blind, placebo-controlled study
67. Psychotherapy for dysthymic disorder
68. Dysthymia in clinical practice: Psychological therapies
69. Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-Months comparison with longitudinal 2-year follow-up of effectiveness and costs
70. Treatment of dysthymia with group cognitive therapy and pharmacotherapy: Clinical symptoms and functional impairments
71. Gender differences in treatment response to sertraline and imipramine in chronic depression
72. Sex differences in response to pharmacotherapy among early onset dysthymics
73. Gender differences in response to combination treatment of chronic depression
74. Sex and treatment of depression: When does it matter?
75. Age-sex differences in response to antidepressant drugs
76. Antidepressant response to paroxetine by gender
77. Forms of atypical depression and their response to antidepressant drugs
78. Sex differences in recurrent depression: Are there any that are significant?
79. Treatment of major depression with psychotherapy or pharmacotherapy-psychotherapy combinations
80. The menstrual cycle and mood disorders
81. Premenstrual exacerbation of depression: One process or two?
82. Psychiatric evaluation of premenstrual changes
83. Premenstrual exacerbation of depression
84. Premenstrual mood changes: Characteristic patterns in women with and without premenstrual syndrome
85. Standardized assessment of dysthymia: Report of a National Institute of Mental Health conference
86. Comparison of DSM-III-R chronic major depression and major depression superimposed on dysthymia (double depression): A study of the validity and value of differential diagnosis
87. The long-term treatment of depression
88. Prevention of recurrent depression with cognitive therapy: Preliminary findings
89. Prevention of relapse in residual depression by cognitive therapy: A controlled trial